Aarkstore - Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2014

Aarkstore Enterprise Aarkstore Enterprise

Description

“Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2014”, provides an overview of the Idiopathic Pulmonary Fibrosiss therapeutic pipeline.
For more details : http://goo.gl/Z85OES

Informations

• Publié par: Shubhangi
• Publié le: 07 mai 2015
• Nombre de lectures: 0
• Langue: English

Extrait

Aarkstore Enterprise


Aarkstore - Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2014
Browse Full Report
@
http://www.aarkstore.com/pharmaceuticals-healthcare/100717/idiopathic-pulmonaryfibrosis-pipeline-review-h2-2014
Published: Sept 2014 | 190 Pages
PDF : $ 2000 | Site Licence: $ 4000 | Enterprise Wide Licence : $ 6000
Summary
“Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2014”, provides an overview of the Fibrosiss therapeutic pipeline.
This Market Research Report provides comprehensive information on the therapeutic
development for Idiopathic Pulmonary Fibrosis, complete with comparative analysis at various
stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration
(RoA) and molecule type, along with latest updates, and featured news and press releases. It also
reviews key players involved in the therapeutic development for Idiopathic Pulmonary Fibrosis and
special features on late-stage and discontinued projects.
Global Markets Directs report features investigational drugs from across globe covering over 20
therapy areas and nearly 3,000 indications. The report is built using data and information sourced
from Global Markets Directs proprietary databases, Company/University websites, SEC filings,
investor presentations and featured press releases from company/university sites and
industryspecific third party sources, put together by Global Markets Directs team. Drug profiles/records
featured in the report undergoes periodic updation following a stringent set of processes that ensures
that all the profiles are updated with the latest set of information. Additionally, including
live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to

Aarkstore Enterprise

gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class products.
Note*: Certain sections in the report may be removed or altered based on the availability and
relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global therapeutic landscape of Idiopathic Pulmonary Fibrosis
- The reviews key pipeline products under drug profile section which includes, product
description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Idiopathic Pulmonary
Fibrosis and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Idiopathic Pulmonary Fibrosis products under development by companies and
universities/research institutes based on information derived from company and industry-specific
sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till
discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Idiopathic Pulmonary Fibrosis pipeline on the basis of target, MoA, route of
administration and molecule type
- Latest news and deals relating related to pipeline products
Reasons to buy
- Provides strategically significant competitor information, analysis, and insights to formulate
effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective
counterstrategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for
Idiopathic Pulmonary Fibrosis
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Idiopathic Pulmonary Fibrosis
pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with
the most attractive projects to enhance and expand business potential and Scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors
that drove them from pipeline

Aarkstore Enterprise

Order full Report with TOC and Sample page
visit:
http://www.aarkstore.com/pharmaceuticals-healthcare/100717/idiopathic-pulmonaryfibrosis-pipeline-review-h2-2014
Table of Contents:
Introduction
REPORT COVERAGE
Idiopathic Pulmonary Fibrosis Overview
Therapeutics Development
Pipeline Products for Idiopathic Pulmonary Fibrosis - Overview for - Comparative Analysis
Idiopathic Pulmonary Fibrosis - Therapeutics under Development by Companies - Investigation by Universities/Institutes
Idiopathic Pulmonary Fibrosis - Pipeline Products Glance
Late Stage Products
Clinical Stage
Early Stage Products
Idiopathic Pulmonary Fibrosis - Products under Development by Companies - Investigation by Universities/Institutes
Idiopathic Pulmonary Fibrosis - Companies Involved in Therapeutics Development
Bristol-Myers Squibb Company
Boehringer Ingelheim GmbH
F. Hoffmann-La Roche Ltd.
Biogen Idec Inc.
Sanofi
GlaxoSmithKline plc
MedImmune, LLC
Gilead Sciences, Inc.
Vectura Group plc
Moerae Matrix, Inc.
FibroGen, Inc.
Chong Kun Dang Pharmaceutical Corp.
InterMune, Inc.
Celgene Corporation
List Of Tables
Number of Products under Development for Idiopathic Pulmonary Fibrosis, H2 2014

Aarkstore Enterprise

Number of Products under Development for Idiopathic Pulmonary Fibrosis - Comparative Analysis,
H2 2014
Number of Products under by Companies, H2 2014 of Development by H2 2014 (Contd..1)
Number of Products under by Companies, H2 2014 (Contd..2) of Investigation by Universities/Institutes, H2 2014
Comparative Analysis by Late Stage Development, H2 2014 by Clinical Stage H2 2014 Analysis by Early Stage H2 2014
Products under Development by Companies, H2 2014
List Of Figures
Number of Products under Development for Idiopathic Pulmonary Fibrosis, H2 2014 of for Fibrosis - Comparative Analysis,
H2 2014
Number of Products under Development by Companies, H2 2014 of Investigation by Universities/Institutes, H2 2014
Comparative Analysis by Clinical Stage Development, H2 2014 by Early Stage Products, H2 2014
Assessment by Monotherapy Products, H2 2014
Number of Products by Top 10 Target, H2 2014 of by Stage and Top 10 Target, H2 2014
Number of Products by Top 10 Mechanism of Action, H2 2014
Related Market Research reports:
 Corticosteroid-Responsive Dermatoses - Pipeline Review, H1 2014
 Hematological Tumor - Pipeline Review, H1 2014
 Inflammation - Pipeline Review, H1 2014
 Opioid Induced Side Effects - Pipeline Review, H1 2014
 Skin Infections - Pipeline Review, H1 2014
 Restenosis - Pipeline Review, H1 2014
 Tauopathies - H1 2014
 Nasopharyngitis (Common Cold) - Pipeline Review, H1 2014
 Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review, H1 2014
 Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2014
About Aarkstore Enterprise

Aarkstore Enterprise
Enterprise is a leading provider of business and financial information and solutions worldwide. We
specialize in providing online market business information on market research reports, books, magazines,
conference at competitive prices, and strive to provide excellent and innovative service to our customers
Contact Details:
Aarkstore Enterprise
Phone: [phone]
Email: [e-mail]
Our Website: http://www.aarkstore.com
Our Blog : http://www.aarkstore.com/blog/
Latest News : http://www.aarkstore.com/news
Facebook: https://www.facebook.com/aarkstoredotcom